<  RETURN TO RESEARCHERS

Publications

Atlas
CoverScan
Digipath
Hepatica
LiverMultiScan
MRCP+
Pathology Solutions
Pharma Solutions
AILD
Autoimmun hepatitits (AIH)
Autoimmune liver disease (AILD)
Autoimmune sclerosis cholangitis (ASC)
Biliary disease
COVID-19
Cardiac lipid accumulation
Cholestatic liver disease
Chronic liver disease
Colorectal liver metastases
Diastolic dysfunction
Diffuse liver disease
Focal liver disease
Genetic sequencing
Haemochromatosis
Hemochromatosis
Hepatic steatosis
Hepatitis C virus (HCV)
Hepatobiliary disease
Hepatocellular carcinoma (HCC)
Iron overload
LV hypertrophy
Liver cancer
Long COVID
Muti-organ impairment
Myocardial steatosis
NAFLD/NASH
Pancreatic cancer
Pancreatic fat
Pancreatitis
Portal hypertension
Primary biliary cholangitis (PBC)
Primary sclerosing cholangitis (PSC)
SARS-COV2
Type 2 diabetes (T2DM)
UK Biobank
Wilson disease
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
A quantitative magnetic resonance cholangiopancreatography metric of intrahepatic biliary dilatation severity detects high-risk primary sclerosing cholangitis
Author:
Selvaraj, E. A., Ba-Ssalamah, A., Poetter-Lang, S., Ridgway, G. R., Brady, J. M., Collier, J., Culver, E. L., Bailey, A., Pavlides, M.
Journal:
Hepatology Communications
Publication Year:
2021
Volume/Issue:
10.1002/hep4.1860. Advance online publication.
Pages:
Digipath
Atlas
Pharma Solutions
CoverScan
Hepatica
LiverMultiScan
Pathology Solutions
MRCP+
UK Biobank
Pancreatitis
Pancreatic cancer
Wilson disease
Cardiac lipid accumulation
Diastolic dysfunction
LV hypertrophy
Myocardial steatosis
Portal hypertension
Iron overload
Haemochromatosis
Hemochromatosis
Hepatobiliary disease
Primary biliary cholangitis (PBC)
Type 2 diabetes (T2DM)
Diffuse liver disease
Cholestatic liver disease
Hepatitis C virus (HCV)
SARS-COV2
Long COVID
Pancreatic fat
Muti-organ impairment
COVID-19
Hepatic steatosis
Chronic liver disease
Hepatocellular carcinoma (HCC)
Colorectal liver metastases
Focal liver disease
Liver cancer
Primary sclerosing cholangitis (PSC)
Biliary disease
Genetic sequencing
NAFLD/NASH
Autoimmune sclerosis cholangitis (ASC)
Autoimmune liver disease (AILD)
Autoimmun hepatitits (AIH)
AILD